3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
628
Neoplasm Metastasis
38
HER2-positive Breast Cancer
33
Breast Neoplasms, Male
30
Inflammatory Breast Neoplasms
20
Brain Neoplasms
18
Stomach Neoplasms
16
Neoplasms
16
Carcinoma, Non-Small-Cell Lung
14
Triple Negative Breast Neoplasms
12
Colorectal Neoplasms
10
Pancreatic Neoplasms
9
Endometrial Neoplasms
9
Ovarian Neoplasms
8
Cardiotoxicity
8
Lung Neoplasms
7
Esophageal Neoplasms
7
Breast Diseases
7
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms
5
Pathologic Complete Response
5
Carcinoma, Ductal, Breast
5
Urinary Bladder Neoplasms
4
Sarcoma
4
HER2-positive Early Breast Cancer
4
HER2 Positive Breast Cancer
4
Carcinoma, Renal Cell
4
Carcinoma, Hepatocellular
4
Thyroid Neoplasms
3
Interventions
tucatinib
1
pertuzumab
1
Trastuzumab
1
Biosimilar Pharmaceuticals
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Breast Cancer With a Isolated Brain Progression
×
Trastuzumab
×
Breast
×
Clear all
NCT05041842
2025-11-17
InTTercePT
UNICANCER
Phase 2
Active not recruiting
53 enrolled